MX2011010616A - Metodos para tratar edema relacionado a isquemia-reperfusion. - Google Patents
Metodos para tratar edema relacionado a isquemia-reperfusion.Info
- Publication number
- MX2011010616A MX2011010616A MX2011010616A MX2011010616A MX2011010616A MX 2011010616 A MX2011010616 A MX 2011010616A MX 2011010616 A MX2011010616 A MX 2011010616A MX 2011010616 A MX2011010616 A MX 2011010616A MX 2011010616 A MX2011010616 A MX 2011010616A
- Authority
- MX
- Mexico
- Prior art keywords
- reperfusion
- methods
- isemaem
- edem
- treat
- Prior art date
Links
- 102100021807 ER degradation-enhancing alpha-mannosidase-like protein 1 Human genes 0.000 title 1
- 101000895701 Homo sapiens ER degradation-enhancing alpha-mannosidase-like protein 1 Proteins 0.000 title 1
- 206010030113 Oedema Diseases 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 150000008271 glucosaminides Chemical class 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16808909P | 2009-04-09 | 2009-04-09 | |
| PCT/US2010/030556 WO2010118334A1 (en) | 2009-04-09 | 2010-04-09 | Methods of treating edema related to ischemia-reperfusion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011010616A true MX2011010616A (es) | 2012-03-14 |
Family
ID=42936599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011010616A MX2011010616A (es) | 2009-04-09 | 2010-04-09 | Metodos para tratar edema relacionado a isquemia-reperfusion. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20120064044A1 (enExample) |
| EP (1) | EP2416651A4 (enExample) |
| JP (1) | JP2012523432A (enExample) |
| KR (1) | KR20120005025A (enExample) |
| CN (1) | CN102458113A (enExample) |
| AU (1) | AU2010233151A1 (enExample) |
| BR (1) | BRPI1010516A2 (enExample) |
| CA (1) | CA2757998A1 (enExample) |
| EA (1) | EA201101349A1 (enExample) |
| IL (1) | IL215604A0 (enExample) |
| MX (1) | MX2011010616A (enExample) |
| SG (1) | SG175133A1 (enExample) |
| WO (1) | WO2010118334A1 (enExample) |
| ZA (1) | ZA201107815B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5562939B2 (ja) * | 2008-04-09 | 2014-07-30 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | アクチン細胞骨格再編成及び細胞間ギャップ形成調節の方法 |
| CN103492572A (zh) * | 2011-03-03 | 2014-01-01 | 夸克医药公司 | 用于治疗肺疾病和损伤的组合物和方法 |
| WO2013082458A1 (en) | 2011-12-02 | 2013-06-06 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
| JP7330893B2 (ja) | 2017-03-10 | 2023-08-22 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 短時間作用型ヘパリンベースの抗凝集剤化合物及び方法 |
| US11993627B2 (en) | 2017-07-03 | 2024-05-28 | The University Of North Carolina At Chapel Hill | Enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharides |
| WO2019090203A1 (en) | 2017-11-03 | 2019-05-09 | The University Of North Carolina At Chapel Hill | Sulfated oligosaccharides having anti-inflammatory activity |
| EP3752182B1 (en) | 2018-02-12 | 2024-05-15 | Inimmune Corporation | Toll-like receptor ligands |
| WO2019246264A1 (en) | 2018-06-20 | 2019-12-26 | The University Of North Carolina At Chapel Hill | Cell protective methods and compositions |
| JP2023501568A (ja) * | 2019-11-13 | 2023-01-18 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 肝虚血再灌流障害におけるヘパラン硫酸（ｈｓ）オリゴ糖の効果 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05139992A (ja) * | 1991-11-13 | 1993-06-08 | Ajinomoto Co Inc | ヒトａｄｆを含有する臓器保護剤 |
| US6113918A (en) * | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| US7960522B2 (en) * | 2003-01-06 | 2011-06-14 | Corixa Corporation | Certain aminoalkyl glucosaminide phosphate compounds and their use |
| JPWO2004085396A1 (ja) * | 2003-03-26 | 2006-06-29 | 三菱ウェルファーマ株式会社 | 虚血再灌流障害の予防または治療剤、臓器保存剤およびスクリーニング方法 |
| US7928132B2 (en) * | 2004-08-06 | 2011-04-19 | Ohio University | Methods for the amelioration of episodes of acute or chronic ulcerative colitis |
| US20060211752A1 (en) * | 2004-03-16 | 2006-09-21 | Kohn Leonard D | Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression |
| EP2170366B1 (en) * | 2007-08-03 | 2013-11-06 | Opsona Therapeutics Limited | Use of tlr-2 antagonists for treatment of reperfusion injury and tissue damage |
| JP5562939B2 (ja) * | 2008-04-09 | 2014-07-30 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | アクチン細胞骨格再編成及び細胞間ギャップ形成調節の方法 |
-
2010
- 2010-04-09 EA EA201101349A patent/EA201101349A1/ru unknown
- 2010-04-09 SG SG2011073475A patent/SG175133A1/en unknown
- 2010-04-09 JP JP2012504890A patent/JP2012523432A/ja active Pending
- 2010-04-09 KR KR1020117026569A patent/KR20120005025A/ko not_active Withdrawn
- 2010-04-09 CN CN2010800259139A patent/CN102458113A/zh active Pending
- 2010-04-09 WO PCT/US2010/030556 patent/WO2010118334A1/en not_active Ceased
- 2010-04-09 EP EP10762505.5A patent/EP2416651A4/en not_active Withdrawn
- 2010-04-09 BR BRPI1010516-6A patent/BRPI1010516A2/pt not_active IP Right Cessation
- 2010-04-09 US US13/263,435 patent/US20120064044A1/en not_active Abandoned
- 2010-04-09 MX MX2011010616A patent/MX2011010616A/es not_active Application Discontinuation
- 2010-04-09 AU AU2010233151A patent/AU2010233151A1/en not_active Abandoned
- 2010-04-09 CA CA2757998A patent/CA2757998A1/en not_active Abandoned
-
2011
- 2011-10-06 IL IL215604A patent/IL215604A0/en unknown
- 2011-10-25 ZA ZA2011/07815A patent/ZA201107815B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG175133A1 (en) | 2011-12-29 |
| EP2416651A1 (en) | 2012-02-15 |
| JP2012523432A (ja) | 2012-10-04 |
| US20120064044A1 (en) | 2012-03-15 |
| WO2010118334A1 (en) | 2010-10-14 |
| CN102458113A (zh) | 2012-05-16 |
| KR20120005025A (ko) | 2012-01-13 |
| ZA201107815B (en) | 2013-04-24 |
| CA2757998A1 (en) | 2010-10-14 |
| EP2416651A4 (en) | 2014-03-26 |
| EA201101349A1 (ru) | 2012-05-30 |
| BRPI1010516A2 (pt) | 2015-08-25 |
| IL215604A0 (en) | 2011-12-29 |
| AU2010233151A1 (en) | 2011-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011010616A (es) | Metodos para tratar edema relacionado a isquemia-reperfusion. | |
| CL2018001223A1 (es) | Locus óptimo de la soja (divisional de solicitud 201601063) | |
| CR20110560A (es) | Métodos de tratamiento para tumores sólidos | |
| NI201100082A (es) | Compuestos de isoindolina para uso en el tratamiento de cáncer. | |
| CR20110686A (es) | Pirimidinonas como ihnibidores de pi3k | |
| UY33627A (es) | Compuestos para tratar enfermedades neurodegenerativas | |
| ECSP12012230A (es) | Proteína de fusión robo1-fc y su utilización en el tratamiento de tumores | |
| ECSP11010778A (es) | Amidofenoxiindazoles útiles como inhibidores de c-met | |
| UY34165A (es) | ?compuestos aldh-2 mitocondriales humanos para el tratamiento de la adicción?. | |
| PA8841901A1 (es) | Compuestos orgánicos | |
| NI201500088A (es) | Inhibidores de histona desmetilasa | |
| GT200800202A (es) | Quinazolinas para la inhibicion de pdk1 | |
| CR11485A (es) | Tratamiento de cancer de mama con un inhibidor de parp solo o en combinacion con agentes anti-tumorales | |
| HN2007015177A (es) | Derivados de triazolopirazina | |
| MX2010009765A (es) | Moleculas pequeñas que contienen boro como agentes anti-inflamatorios. | |
| CR20110326A (es) | Compuestos pirazina como inhibidores de fosfodiesterasa 10 | |
| CL2012000590A1 (es) | Proceso para preparar w-transaminasa (r)-selectiva. | |
| BRPI1000320B8 (pt) | Composições e métodos para tratar sinais de envelhecimento da pele | |
| CR11870A (es) | Composiciones de perácido y 2-hidroxi ácido orgánico y métodos para tratar productos agrícolas | |
| BR112012019302A2 (pt) | imidazo[1,2-b][1,2,4]triazinas como inibidores de c-met | |
| CO2019000753A2 (es) | Métodos para tratar el cáncer de próstata | |
| MX348526B (es) | Composiciones orgánicas para tratar las enfermedades relacionadas con hsf1. | |
| BR112012023836A2 (pt) | composto tricíclicos e inibidores de pbk contendo os mesmos | |
| EA201170294A1 (ru) | Способы лечения реперфузионных повреждений | |
| UY34466A (es) | Proceso para estabilizar contenido bacteriano de treparaciones minerales acuosas que comprenden carbbonatos de calcio. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |